These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 10825461)

  • 1. Ligand-independent activation of estrogen receptor function by 3, 3'-diindolylmethane in human breast cancer cells.
    Riby JE; Chang GH; Firestone GL; Bjeldanes LF
    Biochem Pharmacol; 2000 Jul; 60(2):167-77. PubMed ID: 10825461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytostatic and antiestrogenic effects of 2-(indol-3-ylmethyl)-3,3'-diindolylmethane, a major in vivo product of dietary indole-3-carbinol.
    Chang YC; Riby J; Chang GH; Peng BC; Firestone G; Bjeldanes LF
    Biochem Pharmacol; 1999 Sep; 58(5):825-34. PubMed ID: 10449193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytostatic effects of 3,3'-diindolylmethane in human endometrial cancer cells result from an estrogen receptor-mediated increase in transforming growth factor-alpha expression.
    Leong H; Firestone GL; Bjeldanes LF
    Carcinogenesis; 2001 Nov; 22(11):1809-17. PubMed ID: 11698343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent ligand-independent estrogen receptor activation by 3,3'-diindolylmethane is mediated by cross talk between the protein kinase A and mitogen-activated protein kinase signaling pathways.
    Leong H; Riby JE; Firestone GL; Bjeldanes LF
    Mol Endocrinol; 2004 Feb; 18(2):291-302. PubMed ID: 14645498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The major cyclic trimeric product of indole-3-carbinol is a strong agonist of the estrogen receptor signaling pathway.
    Riby JE; Feng C; Chang YC; Schaldach CM; Firestone GL; Bjeldanes LF
    Biochemistry; 2000 Feb; 39(5):910-8. PubMed ID: 10653634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indole-3-carbinol selectively uncouples expression and activity of estrogen receptor subtypes in human breast cancer cells.
    Sundar SN; Kerekatte V; Equinozio CN; Doan VB; Bjeldanes LF; Firestone GL
    Mol Endocrinol; 2006 Dec; 20(12):3070-82. PubMed ID: 16901971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3,3'-Diindolylmethane (DIM) induces a G(1) cell cycle arrest in human breast cancer cells that is accompanied by Sp1-mediated activation of p21(WAF1/CIP1) expression.
    Hong C; Kim HA; Firestone GL; Bjeldanes LF
    Carcinogenesis; 2002 Aug; 23(8):1297-305. PubMed ID: 12151347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcl-2 family-mediated apoptotic effects of 3,3'-diindolylmethane (DIM) in human breast cancer cells.
    Hong C; Firestone GL; Bjeldanes LF
    Biochem Pharmacol; 2002 Mar; 63(6):1085-97. PubMed ID: 11931841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plant-derived 3,3'-Diindolylmethane is a strong androgen antagonist in human prostate cancer cells.
    Le HT; Schaldach CM; Firestone GL; Bjeldanes LF
    J Biol Chem; 2003 Jun; 278(23):21136-45. PubMed ID: 12665522
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indolo[3,2-b]carbazole: a dietary-derived factor that exhibits both antiestrogenic and estrogenic activity.
    Liu H; Wormke M; Safe SH; Bjeldanes LF
    J Natl Cancer Inst; 1994 Dec; 86(23):1758-65. PubMed ID: 7966413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation and potentiation of interferon-gamma signaling by 3,3'-diindolylmethane in MCF-7 breast cancer cells.
    Riby JE; Xue L; Chatterji U; Bjeldanes EL; Firestone GL; Bjeldanes LF
    Mol Pharmacol; 2006 Feb; 69(2):430-9. PubMed ID: 16267208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of genes regulated by estrogen and diindolylmethane in breast cancer cell lines.
    Mulvey L; Chandrasekaran A; Liu K; Lombardi S; Wang XP; Auborn KJ; Goodwin L
    Mol Med; 2007; 13(1-2):69-78. PubMed ID: 17515958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low levels of 3,3'-diindolylmethane activate estrogen receptor α and induce proliferation of breast cancer cells in the absence of estradiol.
    Marques M; Laflamme L; Benassou I; Cissokho C; Guillemette B; Gaudreau L
    BMC Cancer; 2014 Jul; 14():524. PubMed ID: 25048790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Estrogen receptor alpha as a target for indole-3-carbinol.
    Wang TT; Milner MJ; Milner JA; Kim YS
    J Nutr Biochem; 2006 Oct; 17(10):659-64. PubMed ID: 16488130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resolvin D2 supports MCF-7 cell proliferation via activation of estrogen receptor.
    Al-Zaubai N; Johnstone CN; Leong MM; Li J; Rizzacasa M; Stewart AG
    J Pharmacol Exp Ther; 2014 Oct; 351(1):172-80. PubMed ID: 25077525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aryl hydrocarbon receptor-mediated antiestrogenic and antitumorigenic activity of diindolylmethane.
    Chen I; McDougal A; Wang F; Safe S
    Carcinogenesis; 1998 Sep; 19(9):1631-9. PubMed ID: 9771935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bivalent ligands as probes of estrogen receptor action.
    Bergmann KE; Wooge CH; Carlson KE; Katzenellenbogen BS; Katzenellenbogen JA
    J Steroid Biochem Mol Biol; 1994 Jun; 49(2-3):139-52. PubMed ID: 8031710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synergistic activation of estrogen receptor-mediated transcription by estradiol and protein kinase activators.
    Cho H; Katzenellenbogen BS
    Mol Endocrinol; 1993 Mar; 7(3):441-52. PubMed ID: 7683375
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
    Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
    Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.